Isabelle Lonjon-Domanec
VP Clinical, Medical & Regulatory Affairs France, Novo Nordisk
Isabelle Lonjon-Domanec is listed as VP Clinical, Medical & Regulatory Affairs France, Novo Nordisk. Isabelle spoke at The Patient Centricity & Engagement Conference 2026 in June 2026 (panellist, “Transform Treatment Experiences By Prioritising Quality Of Life, Clear Guidance & Joined-Up Support That Mirrors The Real Challenges Patients Face In 2026”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Isabelle. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
The Patient Centricity & Engagement Conference 2026 24 June 2026
Spoke alongside
People who have shared a session with Isabelle at events on B2DB.
- Anita Powell Founder · Menopause Alliance CIC 1 shared session
- Debra Montague President · Lung Cancer Europe 1 shared session
- Geoff Rollason Patient Advocate 1 shared session
- Victoria Clare CEO · Ovacome 1 shared session
Others from Novo Nordisk
- Antoine Minot Vice President, Global Security 2 sessions
- Francisco Javier Fillat Digital Health & Digital MKT Sr. Manager 2 sessions
- Aparajita Tyagi Global Market Access Lead, Obesity Market Access 1 session
- Catherine Brant Advocacy and Engagement Lead 1 session
- Daniele Granata Principal Modelling Scientist 1 session
- Jens Hummelsiep Senior S&OP Manager 1 session
- Julie Gerlings Sr. Responsible AI Scientist 1 session
- Katherine Jordan Senior Director for Corporate Affairs 1 session
- Leyla Hernandez Donoso Senior Director Evidence, Data & Insights 1 session
- Marie-Louise Møller Lange Master Thesis Student 1 session
- Rajesh Lakshmanamoorthy Principal Product Owner 1 session
- Tina Møller Tagmose Principal Scientist 1 session